Business Context and Reporting Period
Company: Amgen Inc.
Filing Type: Form 8-K (Current Report)
Report Date: August 4, 2026
Reporting Period: Unaudited results for the three and six months ended June 30, 2026.
Key Financial Metrics
The filing serves as a notification of the issuance of a press release containing financial results. The text of this 8-K does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. It confirms the company reports the following metrics in the accompanying press release (Exhibit 99.1):
- GAAP and non-GAAP earnings per share.
- Non-GAAP operating income and operating margin.
- Non-GAAP tax rate and operating expenses (including cost of sales, R&D, and SG&A).
- Free Cash Flow (FCF), defined as operating cash flow minus capital expenditures.
Material Changes and Non-GAAP Adjustments
The filing details the methodology for calculating non-GAAP financial measures, which exclude specific items to facilitate comparisons of ongoing business operations. The following items are excluded from GAAP results to derive non-GAAP figures:
- Acquisition-related expenses: Amortization and impairment of intangible assets (e.g., technology rights, licensing rights) and step-up to fair value of acquired inventory.
- Restructuring and cost savings initiatives: Facilities charges, asset impairments, accelerated depreciation, and severance/benefits for terminated employees.
- Other items: Gains and losses on equity securities and certain items associated with legal proceedings.
The filing does not quantify the dollar amount of these adjustments or the specific material changes in performance versus the prior period.
Guidance, Outlook, and Management Commentary
Management Commentary: Management states that non-GAAP measures are used internally for budgeting, financial planning, resource allocation, and evaluating incentive compensation targets. They believe these measures provide a supplemental evaluation of current operating performance and liquidity (via FCF).
Guidance and Risks: The filing text does not contain specific forward-looking guidance, updated outlook figures, or a detailed discussion of risks and contingencies beyond the standard disclosure that the press release information is not "filed" under Section 18 of the Exchange Act.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated August 4, 2026) for specific revenue, earnings, and cash flow figures.
- Verify the reconciliation tables in the press release to understand the magnitude of excluded acquisition-related and restructuring charges.
- Confirm the specific impact of legal proceedings and equity investment gains/losses on the reported non-GAAP tax rate.
- Check the press release for any updated full-year 2026 guidance or product pipeline updates not detailed in this 8-K summary.